Paper18199029
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.
Chang JY and 6 others. J Infect Dis, 2008. Cited by 793 papers, by iCite.
Cite this record
ConductScience Library. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. Papers, record 18199029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18199029
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Clostridioides difficile | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Feces | Major topic |
| Diarrhea | |
| Drug Administration Schedule | |
| Female | |
| Genetic Variation | |
| Humans | |
| Male | |
| Phylogeny | |
| Recurrence | |
| Reference Values |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02255305 | FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI | Background | ClinicalTrials.gov | |
| NCT02449174 | Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route | Background | ClinicalTrials.gov | |
| NCT05770726 | Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients | Results | ClinicalTrials.gov |
Cited by540
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 793 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881491 | The Trajectory of Gastrointestinal Symptom Experience Following Fecal Microbiota Transplant for Recurrent Clostridioides Difficile Infection. | J Clin Gastroenterol | 2026 | https://conductscience.org/library/papers/42881491 | PubMed |
| 42752228 | Cross-feeding enables robust coexistence between four bacterial species. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42752228 | PubMed |
| 42746219 | Microbiota-mitochondria axis in neurodegenerative disorders and retinal dysfunction: mechanisms and emerging therapeutic opportunities. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42746219 | PubMed |
| 42712936 | Antibiotic-induced gut microbiota dysbiosis and bile acid metabolism: implications for intestinal health, immune regulation, and disease susceptibility. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42712936 | PubMed |
| 42689867 | Gut microbiota and metabolic alterations in participants with flatulence identify Faecalibacterium prausnitzii as a key microbial target for clinical intervention. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42689867 | PubMed |
| 42379287 | The impact of fecal microbiota transplantation on host immunity and epithelial restoration following Clostridioides difficile infection. | Anaerobe | 2026 | https://conductscience.org/library/papers/42379287 | PubMed |
| 42228606 | Microbial shifts in early life: the pediatric gut microbiome and its role in health and disease. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42228606 | PubMed |
| 42184295 | The human microbiome at translational crossroads: an ecological and causal perspective. | Singapore Med J | 2026 | https://conductscience.org/library/papers/42184295 | PubMed |
| 41853554 | Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection. | Front Microbiomes | 2024 | https://conductscience.org/library/papers/41853554 | PubMed |
| 41853542 | Characterization of double humanized BLT-mice with stable engraftment of a human gut bacterial microbiome. | Front Microbiomes | 2024 | https://conductscience.org/library/papers/41853542 | PubMed |
| 41853341 | Chicken caecal enterotypes in indigenous Kadaknath and commercial Cobb chicken lines are associated with Campylobacter abundance and influenced by farming practices. | Front Microbiomes | 2023 | https://conductscience.org/library/papers/41853341 | PubMed |
| 41798990 | Microbiota management: a perspective for kidney transplant patients. | Front Transplant | 2026 | https://conductscience.org/library/papers/41798990 | PubMed |
| 41675702 | Clostridium difficile and gut health: Bacteria, the gut microbiome, and diet. | IMetaOmics | 2025 | https://conductscience.org/library/papers/41675702 | PubMed |
| 41612266 | Intestinal fungal dysbiosis in gestational diabetes mellitus is associated with adverse pregnancy outcomes. | BMC Pregnancy Childbirth | 2026 | https://conductscience.org/library/papers/41612266 | PubMed |
| 41601894 | A novel functional water significantly modulates the gut microbiota and decreases the basal level of inflammation in mice. | Front Nutr | 2025 | https://conductscience.org/library/papers/41601894 | PubMed |
| 41601294 | Sex-Dependent Microbial and Host Profiles Following Fecal Microbiota and Bifidobacterium longum Treatment in Stress-Induced Gut Dysbiosis. | Gut Liver | 2026 | https://conductscience.org/library/papers/41601294 | PubMed |
| 41526647 | Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/41526647 | PubMed |
| 41230019 | Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial. | Ther Adv Gastroenterol | 2025 | https://conductscience.org/library/papers/41230019 | PubMed |
| 41077748 | Predictors of Treatment Response to Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Pilot Study. | J Neurogastroenterol Motil | 2025 | https://conductscience.org/library/papers/41077748 | PubMed |
| 41042595 | Unravelling three-way interactions between Clostridioides difficile, microbiota and the host. | J Med Microbiol | 2025 | https://conductscience.org/library/papers/41042595 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18199029
GET https://conductscience.org/api/papers/v1/18199029/cited_by?page=2